oxycodone has been researched along with Idiopathic Parkinson Disease in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Bruno, V; Farcy, N; Karnik, V; Zamorano, C | 1 |
Buhidma, Y; Duty, S; Leta, V; Malcangio, M; Ray Chaudhuri, K; Rukavina, K; Sportelli, C | 1 |
Dauri, M; Madeo, G; Natoli, S; Pierantozzi, M; Pisani, A; Schirinzi, T; Stefani, A | 1 |
Antonini, A; Tinazzi, M | 1 |
Chaudhuri, KR; DeCesare, J; Ehret, R; Hopp, M; Krygowska-Wajs, A; Lomax, M; Marti, MJ; Martinez-Martin, P; Oksche, A; Rascol, O; Reimer, K; Sátori, M; Trenkwalder, C; Vališ, M | 1 |
Herkes, GK; McKay, D; Meagher, LJ; Needham, M | 1 |
2 review(s) available for oxycodone and Idiopathic Parkinson Disease
Article | Year |
---|---|
Current Status of Pain Management in Parkinson's Disease.
Topics: Acetylcholine Release Inhibitors; Alanine; Analgesics; Antiparkinson Agents; Apomorphine; Benzylamines; Botulinum Toxins, Type A; Deep Brain Stimulation; Dopamine Agonists; Drug Combinations; Duloxetine Hydrochloride; Humans; Levodopa; Naloxone; Oxycodone; Pain; Pain Management; Pain Measurement; Pain Threshold; Parkinson Disease; Tetrahydronaphthalenes; Thiophenes | 2020 |
Pain in Parkinson's disease: new concepts in pathogenesis and treatment.
Topics: Analgesics; Botulinum Toxins; Chronic Pain; Deep Brain Stimulation; Duloxetine Hydrochloride; Humans; Naloxone; Oxycodone; Pain Management; Parkinson Disease | 2019 |
1 trial(s) available for oxycodone and Idiopathic Parkinson Disease
Article | Year |
---|---|
Prolonged-release oxycodone-naloxone for treatment of severe pain in patients with Parkinson's disease (PANDA): a double-blind, randomised, placebo-controlled trial.
Topics: Aged; Analgesics, Opioid; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Female; Humans; Male; Middle Aged; Naloxone; Oxycodone; Pain; Parkinson Disease; Treatment Outcome | 2015 |
3 other study(ies) available for oxycodone and Idiopathic Parkinson Disease
Article | Year |
---|---|
Efficacy and safety profile of prolonged release oxycodone in combination with naloxone (OXN PR) in Parkinson's disease patients with chronic pain.
Topics: Aged; Aged, 80 and over; Chronic Pain; Delayed-Action Preparations; Drug Combinations; Female; Humans; Male; Middle Aged; Naloxone; Oxycodone; Parkinson Disease; Prospective Studies; Quality of Life; Treatment Outcome | 2015 |
Targeting pain in Parkinson's disease.
Topics: Analgesics, Opioid; Female; Humans; Male; Naloxone; Oxycodone; Pain; Parkinson Disease | 2015 |
Parkinsonism-hyperpyrexia syndrome: the role of electroconvulsive therapy.
Topics: Acetaminophen; Acyclovir; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-Anxiety Agents; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antiparkinson Agents; Antiviral Agents; Anxiety; Carbidopa; Ceftriaxone; Cervical Vertebrae; Depression; Dexamethasone; Diazepam; Doxepin; Electroconvulsive Therapy; Humans; Levodopa; Male; Middle Aged; Neuroleptic Malignant Syndrome; Oxycodone; Pain; Parkinson Disease; Selegiline; Spinal Injuries | 2006 |